carvedilol has been researched along with lisinopril in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 13 (38.24) | 29.6817 |
| 2010's | 18 (52.94) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lund-Johansen, P; Omvik, P | 1 |
| Anguita Sánchez, M | 1 |
| Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
| Blann, AD; Chin, BS; Gibbs, CR; Langford, NJ; Lip, GY; Nuttall, SL | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Coglitore, S; Di Bella, G; Patanè, S; Pugliatti, P; Recupero, A | 1 |
| Lee, T | 1 |
| Makarova, SV; Praskurnichiĭ, EA; Savel'eva, SA; Shevchenko, OP; Zhukova, VA | 1 |
| Altenberger, H; Finsterer, J; Stöllberger, C | 1 |
| Parker, T | 1 |
| Bakris, GL; Iyengar, M; Lukas, MA; Ordronneau, P; Weber, MA | 1 |
| Flack, JM | 1 |
| Babkin, AP; Gladkikh, VV; Gulaia, GI; Pershukov, IV | 1 |
| Lee, R | 1 |
| Bank, AJ; Gonzalez-Campoy, JM; Katz, H; Kelly, AS; Metzig, AM; Rudser, KD; Thalin, M | 1 |
| Ahmad, T; Milano, CA; Patel, CB; Rogers, JG | 1 |
| Cohn, JN; Duprez, DA; Grandits, GA; Saul, SM; Zhong, W | 1 |
| Perkins, MJ; Schachter, DT | 1 |
| Fink, A; Guglin, M; Krischer, J; Munster, P | 1 |
| Ayers, AM; Bertino, E; Boudoulas, KD; Franco, V; Guha, A; Jia, K; Liu, E | 1 |
| Bello-Matricaria, L; Fink, A; Guglin, M; Krischer, J; McCaskill-Stevens, W; Munster, PN; Tamura, R | 1 |
| Barac, A; Blaes, A; Lynce, F | 1 |
| Shang, H; Sun, J; Xing, Y; Yang, X | 1 |
| Ozkalayci, F; Tanboga, IH | 1 |
| Doshi, A; Harizi, R; Kate, Y; Pandey, D; Syed, MP | 1 |
| Abdelazeem, B; Barham, W; Khor, SY; Osman, AF | 1 |
2 review(s) available for carvedilol and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prevention and treatment of congestive heart failure in diabetic patients].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Meta-Analysis as Topic; Metoprolol; Prognosis; Propanolamines; Risk Factors; Time Factors | 2002 |
7 trial(s) available for carvedilol and lisinopril
| Article | Year |
|---|---|
[Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
Topics: Acrylates; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Test; Follow-Up Studies; Humans; Hypertension; Imidazoles; Lisinopril; Middle Aged; Propanolamines; Receptor, Angiotensin, Type 1; Thiophenes; Treatment Outcome; Vasodilation | 2008 |
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Propanolamines; Severity of Illness Index; Treatment Outcome | 2010 |
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
Topics: Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Propanolamines; Severity of Illness Index; Treatment Outcome | 2010 |
Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Obesity, Abdominal; Oxidative Stress; Propanolamines | 2012 |
Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.
Topics: Antihypertensive Agents; Blood Pressure; Carbazoles; Cardiovascular System; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Propanolamines | 2013 |
Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Breast Neoplasms; Carbazoles; Cardiotoxicity; Carvedilol; Dose-Response Relationship, Drug; Female; Humans; Lisinopril; Middle Aged; Propanolamines; Prospective Studies; Stroke Volume; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cardiotonic Agents; Carvedilol; Female; Heart; Humans; Lisinopril; Middle Aged; Stroke Volume; Trastuzumab | 2019 |
25 other study(ies) available for carvedilol and lisinopril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular; Female; Follow-Up Studies; Heart Failure; Humans; Lipid Peroxides; Lisinopril; Male; Middle Aged; Oxidative Stress; Propanolamines; Prospective Studies; Risk Factors; Treatment Outcome; von Willebrand Factor | 2003 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Pharmacological washout for the correct evaluation of the head-up tilt testing.
Topics: Aged; Antihypertensive Agents; Carbazoles; Carvedilol; Diagnostic Errors; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Hypotension, Orthostatic; Lisinopril; Propanolamines; Syncope; Tilt-Table Test | 2008 |
Ask the doctor. Does a low ejection fraction doom me to inactivity?
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiac Output, Low; Cardiotonic Agents; Carvedilol; Exercise; Humans; Lisinopril; Myocardial Infarction; Propanolamines; Stroke Volume | 2007 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Echocardiography; Furosemide; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mosaicism; Phenotype; Propanolamines; Spironolactone; Turner Syndrome; Ventricular Dysfunction, Left | 2009 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine | 2009 |
[Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Carvedilol; Cerebrovascular Disorders; Drug Monitoring; Felodipine; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Sodium Chloride, Dietary; Treatment Outcome | 2010 |
Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Carbazoles; Carvedilol; Cholesterol, LDL; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines | 2011 |
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Furosemide; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Lisinopril; Male; Middle Aged; Milrinone; Propanolamines; Severity of Illness Index; Spironolactone | 2012 |
Biventricular Takotsubo cardiomyopathy in Graves hyperthyroidism.
Topics: Adult; Carbazoles; Carvedilol; Drug Therapy, Combination; Electrocardiography; Female; Graves Disease; Humans; Hyperthyroidism; Lisinopril; Methimazole; Propanolamines; Takotsubo Cardiomyopathy; Thyroid Function Tests; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2014 |
Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Carvedilol; Electrocardiography; Female; Humans; Lisinopril; Lung Neoplasms; Middle Aged; Propanolamines; Shock, Cardiogenic; Ventricular Dysfunction, Right | 2017 |
Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All.
Topics: Breast Neoplasms; Cardiotoxicity; Carvedilol; Humans; Lisinopril; Trastuzumab | 2019 |
Effect of Cardioprotective Drugs on Chemotherapy-Induced Heart Failure and New Risk Stratification.
Topics: Antineoplastic Agents; Breast Neoplasms; Cardiotoxicity; Carvedilol; Heart Failure; Humans; Lisinopril; Risk Assessment; Trastuzumab | 2019 |
Strategies to Prevent Cardiotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Cardiotoxicity; Carvedilol; Humans; Lisinopril; Neoplasms; Trastuzumab | 2019 |
A rare case of biventricular non-compaction.
Topics: Cardiomyopathies; Carvedilol; Coronary Artery Disease; Dyspnea; Furosemide; Heart Failure; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2020 |
Recurrent biventricular takotsubo cardiomyopathy with fatal outcome.
Topics: Atorvastatin; Carvedilol; Fatal Outcome; Female; Humans; Lisinopril; Natriuretic Peptide, Brain; Stroke Volume; Takotsubo Cardiomyopathy; Troponin I; Ventricular Function, Left | 2022 |